Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
_____________
FORM
8-K
_____________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
report (Date of earliest event reported): May 11, 2010
PRESTIGE
BRANDS HOLDINGS, INC.
(Exact
Name of Registrant as Specified in Charter)
|
Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
001-32433
(Commission
File Number)
|
20-1297589
(IRS
Employer Identification No.)
|
90 North
Broadway, Irvington, New York 10533
(Address
of Principal Executive Offices)
(914)
524-6810
(Registrant’s
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
£
|
Written
communications pursuant to Rule 425 under the Securities
Act.
|
|
£
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
|
£
|
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
|
£
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
Item
5.02. Departure of Directors or Certain Officers;
Election of Directors; Appoint of Certain Officers; Compensatory Arrangements of
Certain Officers.
(d) On
May 11, 2010, the Board of Directors of Prestige Brands Holdings, Inc. (the
“Company”) appointed Charles Hinkaty to the Board of Directors. At this
time, Mr. Hinkaty has not been appointed to any committees of the Board of
Directors. A subsequent Form 8-K will be filed with the Securities and
Exchange Commission upon Mr. Hinkaty's appointment to any committees of the
Board of Directors.
Item
7.01. Regulation FD Disclosure
On May 17, 2010, the Company issued the
press release that is furnished hereto as Exhibit 99.1 and incorporated by
reference as if fully set forth herein announcing the matter described in Item
5.02 of this Current Report on Form 8-K.
Item
9.01 Financial
Statements and Exhibits.
(d) Exhibits.
See Exhibit Index immediately following
the signature page.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
| PRESTIGE BRANDS HOLDINGS, INC. | |
Date: May
17,
2010
| By: | /s/ Eric S. Klee |
| Name: | Eric S. Klee | |
| Title: | Secretary and General Counsel |
EXHIBIT
INDEX
|
Exhibit
|
Description
|
|
99.1
|
Press Release dated May
17, 2010 announcing the appointment of Charles Hinkaty to Registrant’s
Board of Directors.
|
EXHIBIT
99.1
CHARLES
J. HINKATY APPOINTED TO PRESTIGE BRANDS HOLDINGS
BOARD
OF DIRECTORS
Irvington,
NY, May 17, 2010—Charles J. Hinkaty has been appointed to the Board of Directors
of Prestige Brands Holdings, Inc. (NYSE-PBH), a consumer products company with a
diversified portfolio of well-known brands in over-the-counter healthcare,
household cleaning and personal care categories.
Mr.
Hinkaty brings almost forty years of executive experience in consumer products
to the board. Most recently, he served as President and CEO of Del Laboratories,
Inc. where he was for twenty-three years. His background also includes a long
career with Bristol-Myers Squibb, Inc. in marketing, acquisitions, licensing,
strategic planning, and business development.
“Charlie
has a wealth of experience in the over-the-counter industry,” said Matthew M.
Mannelly, President and CEO of Prestige Brands. “He adds a breadth of valuable
experience to our board in a number of key areas. We look forward to
his counsel, and are delighted to welcome him to the board.”
His past
professional affiliations include having served as Chairman of the Consumer
Healthcare Products Association, one of the industry’s leading trade
organizations. Mr. Hinkaty holds a B.S and an M.S. from Polytechnic
Institute of New York University, and currently serves as a
Trustee.
Among the
products marketed by Prestige Brands are Comet® cleanser, Chloraseptic® sore
throat treatment, Compound W® wart remover, Clear Eyes® eye care products, and
the Little Remedies® line of pediatric over-the-counter healthcare
products.
Contact:
Dean Siegal, Director, Investor Relations & Communications
914-524-6819